In the March-April 2006 edition of Consumer Magazine (of the United States Food and Drug Administration), an important update was provided regarding the safety of selective serotonin reuptake inhibitors for developing babies.
Here is the full update, titled “Paxil and the Risk of Birth Defects”:
“Early results of new studies for Paxil (paroxetine)